Official Publications Incyte Corporation

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 12/05/2026 am IST			5-day change	1st Jan Change
100.32 ^USD	+1.79%		+3.27%	+1.57%

07/05	Incyte Announces 24-Week Data For Opzelura Cream In Adults With Moderate Atopic Dermatitis	CI
02/05	Incyte Announces Fda Approval of Jakafi Xr Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease	CI

10/02	SEC Filing 8K	CO
10/02	Slide show results	CO
10/02	Annual results	CO
10/02	SEC Filing 10K	CO
28/25/28	SEC Filing 8K	CO
28/25/28	SEC Filing 10Q-3	CO
28/25/28	Slide show Q3	CO
28/25/28	3rd quarter results	CO
29/25/29	SEC Filing 8K	CO
29/25/29	SEC Filing 10Q-2	CO
29/25/29	Slide show half-year results	CO
29/25/29	1st-half-year results	CO
10/25/10	Shareholders meeting voting results	CO
29/25/29	Slide show Q1	CO
29/25/29	SEC Filing 8K	CO
29/25/29	SEC Filing 10Q-1	CO
29/25/29	1st quarter results	CO
29/25/29	Proxy Statments	CO
10/25/10	SEC Filing 10K	CO
10/25/10	SEC Filing 8K	CO
10/25/10	Slide show results	CO
10/25/10	Annual results	CO
06/25/06	SEC Filing 8K	CO
29/24/29	SEC Filing 8K	CO
29/24/29	SEC Filing 10Q-3	CO